-
Rasagiline, sold
under the
brand name
Azilect among others, is a
medication which is used in the
treatment of Parkinson's disease. It is used as a monotherapy...
- MAO-B
inhibitor and
antiparkinsonian agent rasagiline ((R)-N-propargyl-1-aminoindan). In
contrast to
rasagiline, it
lacks significant monoamine oxidase inhibition...
- imipramine, desipramine),
monoamine oxidase inhibitors (MAOIs) (e.g.,
rasagiline),
serotonin antagonists and
reuptake inhibitors (SARIs) (e.g., nefazodone)...
-
pharmacologically active and is an
active metabolite of the
antiparkinsonian agent rasagiline.
Through its (R)-enantiomer (R)-1-aminoindane, 1-aminoindane has pharmacological...
- is less
selective for MAO-B
inhibition than AGN-1135 (racemic
rasagiline) or
rasagiline. In
addition to its MAOI activity, SU-11739 has been reported...
- more
potent than D-deprenyl. AGN-1135 (racemic
rasagiline) SU-11739 (racemic N-methylated
rasagiline) Parnham, M. J. (1993). "The
History of l-Deprenyl"...
-
racemic rasagiline or as N-propargyl-1-aminoindane) is a
monoamine oxidase inhibitor (MAOI) that was
never marketed. It is the
racemic form of
rasagiline and...
-
ranolazine (INN)
ranpirnase (INN)
rapacuronium bromide (INN)
Rapamune Raplon rasagiline (INN, USAN)
rasburicase (INN)
raseglurant (INN)
rathyronine (INN) Ratiograstim...
- Parkinson's disease. It was
developed from
structural modification of
rasagiline. The drug acts as a
reversible acetylcholinesterase and butyrylcholinesterase...
-
Apomorphine N04BC08
Piribedil N04BC09
Rotigotine N04BD01
Selegiline N04BD02
Rasagiline N04BD03
Safinamide N04BX01
Tolcapone N04BX02
Entacapone N04BX03 Budipine...
